Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Cash from Investing Activities: 2009-2025

Historic Cash from Investing Activities for Myriad Genetics (MYGN) over the last 16 years, with Sep 2025 value amounting to -$6.2 million.

  • Myriad Genetics' Cash from Investing Activities fell 182.67% to -$6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$27.3 million, marking a year-over-year decrease of 51.67%. This contributed to the annual value of -$11.9 million for FY2024, which is 137.30% down from last year.
  • Myriad Genetics' Cash from Investing Activities amounted to -$6.2 million in Q3 2025, which was up 10.14% from -$6.9 million recorded in Q2 2025.
  • Over the past 5 years, Myriad Genetics' Cash from Investing Activities peaked at $291.0 million during Q3 2021, and registered a low of -$41.3 million during Q1 2022.
  • In the last 3 years, Myriad Genetics' Cash from Investing Activities had a median value of -$6.2 million in 2025 and averaged -$127,273.
  • Per our database at Business Quant, Myriad Genetics' Cash from Investing Activities skyrocketed by 1,601.75% in 2021 and then slumped by 1,190.91% in 2022.
  • Over the past 5 years, Myriad Genetics' Cash from Investing Activities (Quarterly) stood at -$25.9 million in 2021, then tumbled by 37.45% to -$35.6 million in 2022, then surged by 66.29% to -$12.0 million in 2023, then surged by 50.83% to -$5.9 million in 2024, then plummeted by 182.67% to -$6.2 million in 2025.
  • Its last three reported values are -$6.2 million in Q3 2025, -$6.9 million for Q2 2025, and -$8.3 million during Q1 2025.